Felix Biotechnology
UEI: Y3JNYYQ5YHA6
• CAGE: 8JL70
Overview
Awardee Type
Parent
Company Description
We’re creating programmable therapies to protect the world against the coming threat of antimicrobial resistance.
Name
Felix Biotechnology
Website
Headquarters
South San Francisco, CA
United States
United States
Most Recent Award
July 22, 2022
Calculating
Federal grant recipient
FELIX BIOTECHNOLOGY INC
(UEI Y3JNYYQ5YHA6, CAGE 8JL70)
is headquartered in South San Francisco CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in January 2019 and
federally registered in
March 2020.
Federal Award Analysis
Felix Biotechnology federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
FELIX BIOTECHNOLOGY INC
Division Name
FELIX BIOTECHNOLOGY
Division Number
FELIX BIOT
UEI
Y3JNYYQ5YHA6
CAGE Code
8JL70
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 16, 2019
Initial Registration
March 29, 2020
Last Registration
June 14, 2024
Registration Activation
June 26, 2023
Registration Expiration
June 14, 2024
Fiscal Year End
March 31
Reported Entity Types
For Profit Organization
State of Incorporation
CA
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No